Skip to content

BBD Longitudinal Study of Osteogenesis Imperfecta

Rare Diseases Clinical Research Network Brittle Bone Disease Consortium Longitudinal Study of Osteogenesis Imperfecta

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02432625
Enrollment
1000
Registered
2015-05-04
Start date
2015-06-01
Completion date
2031-12-31
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteogenesis Imperfecta

Keywords

Osteogenesis Imperfecta, Collagen, Brittle Bone Disorder, Rare Disease Clinical Research Network, COL1A2

Brief summary

Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. The clinical features of OI represent a continuum varying from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal stature, and normal lifespan. Fractures can occur in any bone, but are most common in the extremities. These disorders can be devastating and progressive and result in deformity, chronic pain, impaired function and loss of quality of life. The overall goal of this study is to answer specific question about the natural history of brittle bone diseases as defined by molecular etiology and to develop the foundation for prospective clinical studies.

Detailed description

The purpose of this natural history study is to perform a long-term follow-up of a large group of people with osteogenesis imperfecta (OI). The research aims are: 1. To collect natural history data on all individuals enrolled in this longitudinal study. The cause of the brittle bone disease will be compared with things like severity, various features and response to treatments. 2. To determine how often people with type I OI have vertebral compression fractures of the spine. 3. To determine how often people with OI develop scoliosis (curvature of the spine). 4. To determine how often people with OI have problems with teeth alignment and how dental health impacts a person's quality of life. 5. To determine the effect of pregnancy in women with OI. There will be a total of 1000 people with OI in this study. Participants will be asked to come in every year if 17Y and younger or every other year if 18Y and older for a total of five years. The following information will be collected at the study visits: Birth History and past surgical history, Current medical history, Scoliosis evaluation, Walking ability Questionnaire, Dental Quality of Life Questionnaire, Scoliosis and fractures Quality of Life Questionnaires, Physical development evaluation, Medications Use The following tests will be performed: Physical exam, dental exam, lung function test, hearing test, mobility test. The following X-rays will be taken: DEXA scan, X-ray of the spine, X-ray of the jaw. Biospecimen (urine and blood) samples will be collected.

Interventions

None listed

Sponsors

Baylor College of Medicine
Lead SponsorOTHER
Shriners Hospitals for Children
CollaboratorOTHER
Hospital for Special Surgery, New York
CollaboratorOTHER
Children's National Research Institute
CollaboratorOTHER
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
CollaboratorOTHER
University of California, Los Angeles
CollaboratorOTHER
Oregon Health and Science University
CollaboratorOTHER
University of Nebraska
CollaboratorOTHER
Alfred I. duPont Hospital for Children
CollaboratorOTHER
University of South Florida
CollaboratorOTHER
Phoenix Children's Hospital
CollaboratorOTHER
Marquette University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Natural History Study: Inclusion Criteria: * Individuals with OI diagnosed by molecular (DNA) analysis OR * Individuals whose clinical history and radiographs are highly suggestive of OI, but whose diagnosis has not been verified by biochemical or molecular studies

Exclusion criteria

* Individuals who are unable to return for their scheduled follow up visits. * Individuals with skeletal dysplasias other than OI * Individuals with OI and a second genetic or syndromic diagnosis Vertebral Compression Fractures component Inclusion criteria • Patients with nonsense or frameshift mutations in COL1A1 or COL1A2 of any age and clinical features of OI type I.

Design outcomes

Primary

MeasureTime frameDescription
Natural History of OI10 yearsThe molecular basis of the brittle bone disease will be correlated with phenotype, disease progression and response to current standard of care therapies.

Secondary

MeasureTime frameDescription
Number Vertebral compression fractures in OI HaploInsufficiency10 yearsNumber and location of Vertebral compression fractures in OI-HI
Incidence of Oral and craniofacial anomalies10 yearsIncidence and progression of oral and craniofacial anomalies as captured by panorex and dental exam
Incidence and progression of scoliosis in OI10 yearsIncidence and progression of scoliosis in OI analyzed by subtype and Cobb Angle assessment
Satisfaction of Oral Health 11Y-14Y10 yearsSatisfaction of Oral health as measure by the Oral health QOL 11-14Yrs
Effect of pregnancy in women with OI10 yearsChange in Spine, Hip, and radius Bone Mineral Density in pregnant women with OI
Satisfaction of Oral Health 15Y+10 yearsSatisfaction of Oral health as measure by the OHIP 20

Countries

Canada, United States

Contacts

CONTACTDianne Nguyen
diannen@bcm.edu713.798.6694
STUDY_CHAIRV. Reid Sutton, M.D.

Baylor College of Medicine

STUDY_CHAIRFrank Rauch, M.D.

McGill University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026